Protagen and VELA Form Strategic Partnership

Vela Laboratories, Vienna, one of the leading companies in the area of GMP-compliant potency and release testing of Biopharmaceuticals, and Protagen AG, Dortmund, a GMP-certified specialist in the characterization of protein drugs form a strategic alliance in customer based analytics and marketing & sales.

Aug 8, 2011

“The fast growing demand for Comparability of Biologics needs creative steps and business models. Protagen and VELA are internationally renowned and well-established contract research labs for complete characterization of Biopharmaceuticals and Biosimilars, and both companies belong to the leading providers of ICH-compliant analytical services. Our customers will benefit from this alliance through more efficient project work and study design“, states Dr. Markus Fido, CEO of VELA Laboratories.

“The technology portfolio and the exceptional expertise of VELA in the area of bioassays for potency determination of therapeutic antibodies, growth factors and protein hormones, will synergistically complement the experience and competences of Protagen. Our customers in the pharmaceutical and biotech sector as well as CROs and CMOs will profit from this alliance through the direct access to a comprehensive service portfolio“, comments Dr. Stefan Müllner, CEO of Protagen AG.

Vela Laboratories, Protagen AG

Medical Device Innovations Report

Triumphs and Challenges in Sustainability

Researched List: Blister Machines for Life Sciences

Medidex, an AI-powered medical chatbot platform, analyzed every pharmaceutical recall from 2012 through 2024, looking at both how often companies recalled products and how dangerous those recalls were.

Study Reveals the U.S. Pharmaceutical Firms with the Most FDA Recalls

An AI healthcare platform analyzed 13 years of FDA data to identify companies with highest recall rates and most dangerous violations.

Through the Line: Packaging and Processing

Through the Line: At-home Test Kits

Packaging Recycling Professionals Gathered in Person and Remotely for this Year's Packaging Recycling Summit

The Barcode Assessment revealed that while most manufacturers are now labeling medical devices with barcodes containing the mandated UDI, healthcare providers aren’t consistently scanning those barcodes at the point of care.

Bridging the Barcode Divide: Challenges in Medical Device UDI Implementation

Claire Lageat, BD Clinical and Human Factors Specialist shared expert insights into how needle choice can impact the self-injection experience.

Improving Self-Injection Delivery of Biologics Through Better Needle Choices

Break out of the ordinary: see what’s new in life sciences packaging

<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>

Medical Device Innovations Report

Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.

Learn More